by University of Alberta Faculty of Medicine & Dentistry University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published today in Nature Communications. The research team led by Luc Berthiaume, cell biology professor in the Faculty of Medicine & Dentistry,...
